MedTrace Logo

Effects of BIONESS in Rehabilitation of Stroke

NCT04767360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-03-15

No results posted yet for this study

Summary

A four-weeks randomized clinical two-period crossover-design study will be conducted. Each patient will be randomized in a two separate consecutive treatment periods (Parallel Group Design). "Group A" will be treated with functional electrical stimulation (FES) and a second "Gruppe B" will be treated without FES for two weeks. After this period Group A and Group B will switched.

Conditions

Interventions

DEVICE

Bioness-300

Therapeutic treatment of foot drop with the electrical stimulation device Bioness L300.

Sponsors & Collaborators

  • Peter Young Neurological Clinic Medicalpark Bad Feilnbach, Germany

    collaborator UNKNOWN

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Benedikt Schoser, MD · Friedrich-Baur-Institute, Dep. of Neurology LMU Klinikum Munich Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-10
Primary Completion
2021-10-19
Completion
2022-12-12

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04767360 on ClinicalTrials.gov